Kavsak, PA; Lam, CSP; Saenger, AK; Aakre, KM; Body, R; Hammarsten, O; Collinson, P; Ordóñez-Llanos, J; Omland, T; Jaffe, AS; et al. Kavsak, PA; Lam, CSP; Saenger, AK; Aakre, KM; Body, R; Hammarsten, O; Collinson, P; Ordóñez-Llanos, J; Omland, T; Jaffe, AS; Apple, FS (2021) Biomarker Testing Considerations in the Evaluation and Management of Patients with Heart Failure: Perspectives from the International Federation of Clinical Chemistry and Laboratory Medicine Committee. J Card Fail, 27 (12). pp. 1456-1461. ISSN 1532-8414 https://doi.org/10.1016/j.cardfail.2021.06.018
SGUL Authors: Collinson, Paul

	Microsoft Word (.docx) Accepted Version Available under License Creative Commons Attribution Non-commercial No Derivatives. Download (37kB)
	Microsoft Word (.docx) (Table 1) Accepted Version Available under License Creative Commons Attribution Non-commercial No Derivatives. Download (40kB)

Item Type:	Article
Additional Information:	© 2021. This manuscript version is made available under the CC-BY-NC-ND 4.0 license https://creativecommons.org/licenses/by-nc-nd/4.0/
Keywords:	clinical chemistry, heart failure, laboratory medicine, natriuretic peptides, 1103 Clinical Sciences, 1102 Cardiorespiratory Medicine and Haematology, Cardiovascular System & Hematology
SGUL Research Institute / Research Centre:	Academic Structure > Molecular and Clinical Sciences Research Institute (MCS)
Journal or Publication Title:	J Card Fail
ISSN:	1532-8414
Language:	eng
Dates:	Date Event December 2021 Published 10 July 2021 Published Online 17 June 2021 Accepted
Publisher License:	Creative Commons: Attribution-Noncommercial-No Derivative Works 4.0
PubMed ID:	34256137
	Go to PubMed abstract
URI:	https://openaccess.sgul.ac.uk/id/eprint/113555
Publisher's version:	https://doi.org/10.1016/j.cardfail.2021.06.018

Actions (login required)

Edit Item